[{"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":2295000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":2290000000.0,"RevenuesConverted_1_Q3_USD":10540000000.0,"RevenuesConverted_3_Q3_USD":31450000000.0,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.45,"Assets_0_Q3_USD":125536000000.0,"EarningsPerShareBasic_1_Q3_USD":0.83,"NetIncomeLossConverted_1_Q3_USD":1878000000.0,"EarningsPerShareDiluted_3_Q3_USD":0.44,"EarningsPerShareDiluted_1_Q3_USD":0.82,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":10382000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":2260000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":2257000000.0,"StockholdersEquityConverted_0_Q3_USD":50230000000.0,"NetIncomeLossConverted_3_Q3_USD":1012000000.0,"StockholdersEquity_0_Q3_USD":50158000000.0,"EarningsPerShareBasic_3_Q3_USD":0.45,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20201105"}]